Research Article

Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas

Table 2

Primary antibodies used in the present study.

AntibodyCloneDilutionPretreatmentManufacturer

Anti-Ki-67MIB-11/200WB + TEDakoCytomation, Glostrup, Denmark
Anti-cyclin D1SP4PredilutedWBMaster Diagnostica, Spain
Anti-cyclin E113A31/50WBNovocastra Leica Biosystems, Newcastle upon Tyne, UK
Anti-cyclin A26E61/10WBNovocastra Leica Biosystems, Newcastle upon Tyne, UK
Anti-cyclin B17A91/10WBNovocastra Leica Biosystems, Newcastle upon Tyne, UK

WB: waterbath at 98°C 30 minutes; TE: tris-ethylenediaminetetraacetic acid (EDTA).